Journal of Pediatric and Adolescent Gynecology
Volume 19, Issue 4 , Pages 307-312 , August 2006

What's Your Diagnosis? Nine-year-old Girl with a Pubic Rash Gone Incognito

  • Jonathan D.K. Trager, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Jonathan D.K. Trager, MD, Adolescent-Young Adult Medicine of Great Neck, LLC, 212 Middle Neck Road, Suite #5, Great Neck, NY 11021

References 

  1. Sobera JO, Elewski BE. Fungal diseases. In:  Bolognia JL,  Jorizzo JL,  Rapini RP editor. Dermatology. Mosby: Edinburgh; 2003;p. 1171–1186
  2. Noble SL, Forbes RC, Stamm PL. Diagnosis and management of common tinea infections. Am Fam Phys. 1998;58:163
  3. Pariser D, Opper C. An in-office diagnostic procedure to detect dermatophytes in a nationwide study of onychomycosis patients. Manag Care. 2002;11:43
  4. Ives FA. Marks: Tinea incognito. Br Med J. 1968;3:149
  5. Wacker J, Durani BK, Hartschuh W. Bizarre annular lesion emerging as tinea incognito. Mycoses. 2004;47:447
  6. Oklota CA, Brodell RT. Uncovering tinea incognito. Topical corticosteroids can mask typical features of ringworm. Postgrad Med. 2004;116:65
  7. Solomon BA, Glass AT, Rabbin PR. Tinea incognito and “over-the-counter” potent topical steroids. Cutis. 1996;58:295
  8. Jacobs JA, Kolbach DN, Vermeulen AH, et al. Tinea incognito due to Trichophyton rubrum after local steroid therapy. Clin Infect Dis. 2001;33:E142
  9. Siddaiah N, Erickson Q, Miller G, et al. Tacrolimus-induced tinea incognito. Cutis. 2004;73:237
  10. Crawford KM, Bostrom P, Russ B, et al. Pimecrolimus-induced tinea incognito. Skinmed. 2004;3:352
  11. Alston SJ, Cohen BA, Braun M. Persistent and recurrent tinea corporis in children treated with combination antifungal/corticosteroid agents. Pediatrics. 2003;111:201
  12. Lotrisone CreamR/LotrisoneR Lotion package insert. Schering-Plough
  13. Railan D, Wilson JK, Feldman SR, Fleischer AB. Pediatricians who prescribe clotrimazole-betamethasone dipropionate (Lotrisone) often utilize it in inappropriate settings regardless of their knowledge of the drug's potency. Dermatol Online J. 2002;8:3
  14. Fleischer AB, Feldman SR. Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians. Clin Ther. 1999;21:1725
  15. Greenberg HL, Shwayder TA, Bieszk N, et al. Clotrimazole/betamethasone dipropionate: a review of costs and complications in the treatment of common cutaneous fungal infections. Pediatr Dermatol. 2002;19:78
  16. Gupta AK. Systemic antifungal agents. In:  Wolverton SE editors. Comprehensive Dermatologic Therapy. Philadelphia: W.B. Saunders; 2001;p. 55–84
  17. Hengge UR, Ruzicka T, Schwartz RA, et al. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54:1

PII: S1083-3188(06)00173-2

doi: 10.1016/j.jpag.2006.05.015

Journal of Pediatric and Adolescent Gynecology
Volume 19, Issue 4 , Pages 307-312 , August 2006

Article Tools

* Image Usage & Resolution